Lipocine (LPCN) Insider Trading & Ownership $3.27 -0.05 (-1.51%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$3.34 +0.07 (+2.17%) As of 05:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lipocine (NASDAQ:LPCN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.35%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$160.85KNumber OfInsiders Selling(Last 3 Years)0 Get LPCN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LPCN Insider Buying and Selling by Quarter Lipocine Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/25/2023Mahesh V PatelCEOBuy8,706$5.03$43,791.18 3/24/2023Mahesh V PatelCEOBuy8,823$5.44$47,997.12 3/20/2023Richard Dana OnoDirectorBuy235$5.78$1,358.30 3/17/2023Mahesh V PatelCEOBuy2,941$5.61$16,499.01 11/22/2022Spyros PapapetropoulosDirectorBuy1,278$7.99$10,211.22 9/27/2022Mahesh V PatelCEOBuy5,882$6.97$40,997.54 (Data available from 1/1/2013 forward) LPCN Insider Trading Activity - Frequently Asked Questions Who is on Lipocine's Insider Roster? The list of insiders at Lipocine includes Mahesh V Patel, Richard Dana Ono, and Spyros Papapetropoulos. Learn more on insiders at LPCN. What percentage of Lipocine stock is owned by insiders? 6.35% of Lipocine stock is owned by insiders. Learn more on LPCN's insider holdings. Lipocine Key ExecutivesDr. Mahesh V. Patel Ph.D. (Age 67)Co-Founder, Interim Principal Financial Officer, Director, President & CEO Compensation: $762.53kMs. Krista Fogarty (Age 56)Principal Accounting Officer & Corporate Controller Compensation: $321.07kDr. Nachiappan Chidambaram Ph.D. (Age 55)Senior Vice President of Research & Development Compensation: $385.71kMr. Logan Morse (Age 54)Vice President of Sales, Marketing & Operations Compensation: $413.58k More Insider Trading Tools from MarketBeat Related Companies ADAP Insider Trades VRCA Insider Trades STRO Insider Trades ANRO Insider Trades CLSD Insider Trades ASRT Insider Trades MGX Insider Trades BMEA Insider Trades IZTC Insider Trades PMVP Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Do They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold? This page (NASDAQ:LPCN) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipocine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.